{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:39:51Z","timestamp":1790375991302,"version":"4.1.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s11899-018-0429-y","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T01:39:26Z","timestamp":1518572366000},"page":"25-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Updates of Peripheral T Cell Lymphomas Based on the 2017 WHO Classification"],"prefix":"10.1007","volume":"13","author":[{"given":"Parwiz J.","family":"Siaghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Y.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"key":"429_CR1","unstructured":"\u2022 Swerdlow SH, Campo E, Harris NL, et al. WHO classification of Tumours of Haematopoietic and Lymphoid Tissues (ed revised 4th): International Agency for Research on Cancer Lyon; 2017. This reference was particularly of interest because it highlights updates as well as the theory behind the changes in the classification for 2017 described by the Editors of the WHO."},{"issue":"25","key":"429_CR2","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124\u201330. https:\/\/doi.org\/10.1200\/JCO.2008.16.4558.","journal-title":"J Clin Oncol"},{"issue":"6","key":"429_CR3","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/PAS.0000000000000188","volume":"38","author":"ED Hsi","year":"2014","unstructured":"Hsi ED, Said J, Macon WR, et al. Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T\/NK-cell lymphomas. A North American PTCL study group project. Am J Surg Pathol. 2014;38(6):768\u201375.","journal-title":"Am J Surg Pathol"},{"issue":"19","key":"429_CR4","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"J Iqbal","year":"2014","unstructured":"\u2022\u2022 Iqbal J, Wright G, Wang C, et al. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood. 2014;123(19):2915\u201323. This article is also of higher interest because it studied gene expression profiles of over 350 PTCLs and identified to major molecular subgroups that are important for prognosis (GATA3 and TBX21).","journal-title":"Blood"},{"issue":"20","key":"429_CR5","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390.","journal-title":"Blood"},{"issue":"2","key":"429_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/his.12251","volume":"64","author":"AD Attygalle","year":"2014","unstructured":"Attygalle AD, Cabecadas J, Gaulard P, et al. Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology. Histopathology. 2014;64(2):171\u201399.","journal-title":"Histopathology"},{"issue":"5","key":"429_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","volume":"33","author":"Y Huang","year":"2009","unstructured":"Huang Y, Moreau A, Dupuis J, et al. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol. 2009;33(5):682\u201390.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"429_CR8","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1097\/PAS.0b013e31817f123e","volume":"32","author":"SM Rodriguez-Pinilla","year":"2008","unstructured":"Rodriguez-Pinilla SM, Atienza L, Murillo C, et al. Peripheral T-cell lymphoma with follicular T-cell markers. Am J Surg Pathol. 2008;32(12):1787\u201399.","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"429_CR9","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.humpath.2012.05.002","volume":"43","author":"S Hu","year":"2012","unstructured":"Hu S, Young KH, Konoplev SN, Medeiros LJ. Follicular T-cell lymphoma: a member of an emerging family of follicular helper T-cell derived T-cell lymphomas. Hum Pathol. 2012;43(11):1789\u201398. https:\/\/doi.org\/10.1016\/j.humpath.2012.05.002.","journal-title":"Hum Pathol"},{"issue":"9","key":"429_CR10","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","volume":"123","author":"O Odejide","year":"2014","unstructured":"Odejide O, Weigert O, Lane AA, et al. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood. 2014;123(9):1293\u20136.","journal-title":"Blood"},{"issue":"7","key":"429_CR11","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","volume":"120","author":"F Lemonnier","year":"2012","unstructured":"Lemonnier F, Couronne L, Parrens M, et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood. 2012;120(7):1466\u20139.","journal-title":"Blood"},{"issue":"3","key":"429_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/PAS.0000000000000555","volume":"40","author":"SL Ondrejka","year":"2016","unstructured":"Ondrejka SL, Grzywacz B, Bodo J, et al. Angioimmunoblastic T-cell lymphomas with the RHOA p.Gly17Val mutation have classic clinical and pathologic features. Am J Surg Pathol. 2016;40(3):335\u201341.","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 1","key":"429_CR13","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1038\/modpathol.2012.181","volume":"26","author":"ES Jaffe","year":"2013","unstructured":"Jaffe ES, Nicolae A, Pittaluga S. Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls. Mod Pathol. 2013;26(Suppl 1):S71\u201387. https:\/\/doi.org\/10.1038\/modpathol.2012.181.","journal-title":"Mod Pathol"},{"issue":"7","key":"429_CR14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/PAS.0b013e31802d68e9","volume":"31","author":"AD Attygalle","year":"2007","unstructured":"Attygalle AD, Kyriakou C, Dupuis J, et al. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol. 2007;31(7):1077\u201388.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"429_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/modpathol.2009.12","volume":"22","author":"M Rodriguez-Justo","year":"2009","unstructured":"Rodriguez-Justo M, Attygalle AD, Munson P, Roncador G, Marafioti T, Piris MA. Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers. Mod Pathol. 2009;22(6):753\u201361. https:\/\/doi.org\/10.1038\/modpathol.2009.12.","journal-title":"Mod Pathol"},{"issue":"6","key":"429_CR16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/PAS.0b013e3182785610","volume":"37","author":"A Nicolae","year":"2013","unstructured":"Nicolae A, Pittaluga S, Venkataraman G, et al. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin\/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol. 2013;37(6):816\u201326.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"429_CR17","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1309\/6UTX-GVC0-12ND-JJEU","volume":"117","author":"A Zettl","year":"2002","unstructured":"Zettl A, Lee S, Rudiger T, et al. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol. 2002;117(3):368\u201379.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"429_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M, et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol. 2013;31(2):240\u20136.","journal-title":"J Clin Oncol"},{"issue":"4","key":"429_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1365-2559.2011.03981.x","volume":"59","author":"C Agostinelli","year":"2011","unstructured":"Agostinelli C, Hartmann S, Klapper W, et al. Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert\u2019s personal archive. Histopathology. 2011;59(4):679\u201391.","journal-title":"Histopathology"},{"issue":"11","key":"429_CR20","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1097\/PAS.0b013e318268d9ff","volume":"36","author":"J Moroch","year":"2012","unstructured":"Moroch J, Copie-Bergman C, de Leval L, et al. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics. Am J Surg Pathol. 2012;36(11):1636\u201346.","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"429_CR21","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L de Leval","year":"2007","unstructured":"de Leval L, Rickman DS, Thielen C, Reynies A, Huang YL, Delsol G, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood. 2007;109(11):4952\u201363. https:\/\/doi.org\/10.1182\/blood-2006-10-055145.","journal-title":"Blood"},{"issue":"4","key":"429_CR22","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","volume":"102","author":"MP Dobay","year":"2017","unstructured":"Dobay MP, Lemonnier F, Missiaglia E, et al. Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin. Haematologica. 2017;102(4):e148\u201351.","journal-title":"Haematologica"},{"issue":"2","key":"429_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ng.2873","volume":"46","author":"T Palomero","year":"2014","unstructured":"Palomero T, Couronne L, Khiabanian H, et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet. 2014;46(2):166\u201370.","journal-title":"Nat Genet"},{"issue":"2","key":"429_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng.2872","volume":"46","author":"M Sakata-Yanagimoto","year":"2014","unstructured":"Sakata-Yanagimoto M, Enami T, Yoshida K, et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(2):171\u20135.","journal-title":"Nat Genet"},{"issue":"15","key":"429_CR25","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","volume":"126","author":"C Wang","year":"2015","unstructured":"Wang C, McKeithan TW, Gong Q, Zhang W, Bouska A, Rosenwald A, et al. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. Blood. 2015;126(15):1741\u201352. https:\/\/doi.org\/10.1182\/blood-2015-05-644591.","journal-title":"Blood"},{"issue":"4","key":"429_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ng.2916","volume":"46","author":"HY Yoo","year":"2014","unstructured":"Yoo HY, Sung MK, Lee SH, Kim S, Lee H, Park S, et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(4):371\u20135. https:\/\/doi.org\/10.1038\/ng.2916.","journal-title":"Nat Genet"},{"issue":"1","key":"429_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","volume":"20","author":"C Quivoron","year":"2011","unstructured":"Quivoron C, Couronne L, Della Valle V, et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell. 2011;20(1):25\u201338. https:\/\/doi.org\/10.1016\/j.ccr.2011.06.003.","journal-title":"Cancer Cell"},{"issue":"8","key":"429_CR28","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","volume":"119","author":"RA Cairns","year":"2012","unstructured":"Cairns RA, Iqbal J, Lemonnier F, Kucuk C, de Leval L, Jais JP, et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood. 2012;119(8):1901\u20133. https:\/\/doi.org\/10.1182\/blood-2011-11-391748.","journal-title":"Blood"},{"issue":"2","key":"429_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.leu.2404045","volume":"20","author":"B Streubel","year":"2006","unstructured":"Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia. 2006;20(2):313\u20138. https:\/\/doi.org\/10.1038\/sj.leu.2404045.","journal-title":"Leukemia"},{"issue":"15","key":"429_CR30","doi-asserted-by":"publisher","first-page":"6193","DOI":"10.1158\/0008-5472.CAN-08-3719","volume":"70","author":"C Dierks","year":"2010","unstructured":"Dierks C, Adrian F, Fisch P, et al. The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease. Cancer Res. 2010;70(15):6193\u2013204.","journal-title":"Cancer Res"},{"issue":"9","key":"429_CR31","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1097\/PAS.0b013e3182991415","volume":"37","author":"AD Attygalle","year":"2013","unstructured":"Attygalle AD, Feldman AL, Dogan A. ITK\/SYK translocation in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2013;37(9):1456\u20137. https:\/\/doi.org\/10.1097\/PAS.0b013e3182991415.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"429_CR32","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1182\/blood-2005-03-1306","volume":"107","author":"MA Rizvi","year":"2006","unstructured":"Rizvi MA, Evens AM, Tallman MS, Nelson BP, Rosen ST. T-cell non-Hodgkin lymphoma. Blood. 2006;107(4):1255\u201364. https:\/\/doi.org\/10.1182\/blood-2005-03-1306.","journal-title":"Blood"},{"issue":"12","key":"429_CR33","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1097\/PAS.0000000000000503","volume":"39","author":"MP Menon","year":"2015","unstructured":"Menon MP, Nicolae A, Meeker H, et al. Primary CNS T-cell lymphomas: a clinical, morphologic, Immunophenotypic, and molecular analysis. Am J Surg Pathol. 2015;39(12):1719\u201329.","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"429_CR34","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/j.humpath.2013.03.002","volume":"44","author":"E Hayashi","year":"2013","unstructured":"Hayashi E, Takata K, Sato Y, Tashiro Y, Tachiyama Y, Sawada-Kitamura S, et al. Distinct morphologic, phenotypic, and clinical-course characteristics of indolent peripheral T-cell lymphoma. Hum Pathol. 2013;44(9):1927\u201336. https:\/\/doi.org\/10.1016\/j.humpath.2013.03.002.","journal-title":"Hum Pathol"},{"key":"429_CR35","doi-asserted-by":"crossref","unstructured":"Bellei M, Sabattini E, Pesce EA, et al. Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative study. Hematol Oncol. 2016.","DOI":"10.1002\/hon.2316"},{"issue":"10","key":"429_CR36","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1097\/PAS.0000000000000295","volume":"38","author":"SH Swerdlow","year":"2014","unstructured":"Swerdlow SH, Jaffe ES, Brousset P, Chan JK, de Leval L, Gaulard P, et al. Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies. Am J Surg Pathol. 2014;38(10):e60\u201371. https:\/\/doi.org\/10.1097\/PAS.0000000000000295.","journal-title":"Am J Surg Pathol"},{"issue":"16","key":"429_CR37","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","volume":"24","author":"P Went","year":"2006","unstructured":"Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E, et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol. 2006;24(16):2472\u20139. https:\/\/doi.org\/10.1200\/JCO.2005.03.6327.","journal-title":"J Clin Oncol"},{"issue":"8","key":"429_CR38","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.3324\/haematol.2013.084913","volume":"98","author":"E Sabattini","year":"2013","unstructured":"Sabattini E, Pizzi M, Tabanelli V, et al. CD30 expression in peripheral T-cell lymphomas. Haematologica. 2013;98(8):e81\u20132.","journal-title":"Haematologica"},{"issue":"12","key":"429_CR39","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1097\/00000478-200312000-00003","volume":"27","author":"TS Barry","year":"2003","unstructured":"Barry TS, Jaffe ES, Sorbara L, Raffeld M, Pittaluga S. Peripheral T-cell lymphomas expressing CD30 and CD15. Am J Surg Pathol. 2003;27(12):1513\u201322. https:\/\/doi.org\/10.1097\/00000478-200312000-00003.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"429_CR40","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00428-004-1077-2","volume":"445","author":"E Geissinger","year":"2004","unstructured":"Geissinger E, Odenwald T, Lee SS, et al. Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert\u2019s) variant are often derived from CD8(+) cytotoxic T-cells. Virchows Arch. 2004;445(4):334\u201343.","journal-title":"Virchows Arch"},{"issue":"6","key":"429_CR41","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/j.1365-2559.2011.04069.x","volume":"59","author":"S Hartmann","year":"2011","unstructured":"Hartmann S, Agostinelli C, Klapper W, et al. Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel lymph node registry: what is Lennert's lymphoma nowadays? Histopathology. 2011;59(6):1173\u201382.","journal-title":"Histopathology"},{"issue":"7","key":"429_CR42","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.prp.2013.04.013","volume":"209","author":"SY Ha","year":"2013","unstructured":"Ha SY, Sung J, Ju H, Karube K, Kim SJ, Kim WS, et al. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study. Pathol Res Pract. 2013;209(7):448\u201354. https:\/\/doi.org\/10.1016\/j.prp.2013.04.013.","journal-title":"Pathol Res Pract"},{"issue":"6","key":"429_CR43","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1309\/LYXN3RGF7D7KPYG0","volume":"127","author":"SH Swerdlow","year":"2007","unstructured":"Swerdlow SH. T-cell and NK-cell posttransplantation lymphoproliferative disorders. Am J Clin Pathol. 2007;127(6):887\u201395. https:\/\/doi.org\/10.1309\/LYXN3RGF7D7KPYG0.","journal-title":"Am J Clin Pathol"},{"issue":"24","key":"429_CR44","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1200\/JCO.2012.42.5611","volume":"31","author":"PP Piccaluga","year":"2013","unstructured":"Piccaluga PP, Fuligni F, De Leo A, et al. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study. J Clin Oncol. 2013;31(24):3019\u201325.","journal-title":"J Clin Oncol"},{"issue":"11","key":"429_CR45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/bcj.2014.78","volume":"4","author":"MA Laginestra","year":"2014","unstructured":"Laginestra MA, Piccaluga PP, Fuligni F, Rossi M, Agostinelli C, Righi S, et al. Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified. Blood Cancer J. 2014;4(11):259. https:\/\/doi.org\/10.1038\/bcj.2014.78.","journal-title":"Blood Cancer J"},{"issue":"12","key":"429_CR46","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1182\/blood-2012-08-447375","volume":"122","author":"C Liu","year":"2013","unstructured":"Liu C, Iqbal J, Teruya-Feldstein J, et al. MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood. 2013;122(12):2083\u201392.","journal-title":"Blood"},{"issue":"9","key":"429_CR47","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","volume":"28","author":"R Piva","year":"2010","unstructured":"Piva R, Agnelli L, Pellegrino E, et al. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol. 2010;28(9):1583\u201390.","journal-title":"J Clin Oncol"},{"issue":"19","key":"429_CR48","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1182\/blood-2013-12-544809","volume":"123","author":"T Wang","year":"2014","unstructured":"Wang T, Feldman AL, Wada DA, Lu Y, Polk A, Briski R, et al. GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood. 2014;123(19):3007\u201315. https:\/\/doi.org\/10.1182\/blood-2013-12-544809.","journal-title":"Blood"},{"issue":"9","key":"429_CR49","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","volume":"124","author":"ER Parrilla Castellar","year":"2014","unstructured":"\u2022\u2022 Parrilla Castellar ER, Jaffe ES, Said JW, et al. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood. 2014;124(9):1473\u201380. This article is of high interest because it describes translocations in ALCL, ALK-negative that were not previously described (\n                              DUSP22 and TP63\n                              ).","journal-title":"Blood"},{"issue":"1","key":"429_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1182\/blood-2014-10-567461","volume":"126","author":"G Hapgood","year":"2015","unstructured":"Hapgood G, Savage KJ. The biology and management of systemic anaplastic large cell lymphoma. Blood. 2015;126(1):17\u201325. https:\/\/doi.org\/10.1182\/blood-2014-10-567461.","journal-title":"Blood"},{"issue":"12","key":"429_CR51","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","volume":"96","author":"H Stein","year":"2000","unstructured":"Stein H, Foss HD, Durkop H, et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2000;96(12):3681\u201395.","journal-title":"Blood"},{"issue":"1","key":"429_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/PAP.0000000000000047","volume":"22","author":"X Xing","year":"2015","unstructured":"Xing X, Feldman AL. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous. Adv Anat Pathol. 2015;22(1):29\u201349. https:\/\/doi.org\/10.1097\/PAP.0000000000000047.","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"429_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","volume":"40","author":"RL King","year":"2016","unstructured":"King RL, Dao LN, ED MP, et al. Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements. Am J Surg Pathol. 2016;40(1):36\u201343. https:\/\/doi.org\/10.1097\/PAS.0000000000000500.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"429_CR54","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/PAS.0b013e3182487158","volume":"36","author":"FC Eberle","year":"2012","unstructured":"Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, et al. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Am J Surg Pathol. 2012;36(5):716\u201325. https:\/\/doi.org\/10.1097\/PAS.0b013e3182487158.","journal-title":"Am J Surg Pathol"},{"key":"429_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.humpath.2017.01.003","volume":"64","author":"X Wang","year":"2017","unstructured":"Wang X, Boddicker RL, Dasari S, Sidhu JS, Kadin ME, Macon WR, et al. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping. Hum Pathol. 2017;64:19\u201327. https:\/\/doi.org\/10.1016\/j.humpath.2017.01.003.","journal-title":"Hum Pathol"},{"issue":"2","key":"429_CR56","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","volume":"32","author":"RN Miranda","year":"2014","unstructured":"Miranda RN, Aladily TN, Prince HM, et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol. 2014;32(2):114\u201320. https:\/\/doi.org\/10.1200\/JCO.2013.52.7911.","journal-title":"J Clin Oncol"},{"issue":"3","key":"429_CR57","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/PRS.0000000000001033","volume":"135","author":"GS Brody","year":"2015","unstructured":"Brody GS, Deapen D, Taylor CR, et al. Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg. 2015;135(3):695\u2013705.","journal-title":"Plast Reconstr Surg"},{"issue":"17","key":"429_CR58","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1001\/jama.2008.585","volume":"300","author":"D de Jong","year":"2008","unstructured":"de Jong D, Vasmel WL, de Boer JP, Verhave G, Barb\u00e9 E, Casparie MK, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA. 2008;300(17):2030\u20135. https:\/\/doi.org\/10.1001\/jama.2008.585.","journal-title":"JAMA"},{"issue":"5","key":"429_CR59","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1097\/PRS.0000000000003282","volume":"139","author":"EL Doren","year":"2017","unstructured":"Doren EL, Miranda RN, Selber JC, Garvey PB, Liu J, Medeiros LJ, et al. U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2017;139(5):1042\u201350. https:\/\/doi.org\/10.1097\/PRS.0000000000003282.","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"429_CR60","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/CEJ.0b013e328350b0ae","volume":"21","author":"J Largent","year":"2012","unstructured":"Largent J, Oefelein M, Kaplan HM, Okerson T, Boyle P. Risk of lymphoma in women with breast implants: analysis of clinical studies. Eur J Cancer Prev. 2012;21(3):274\u201380. https:\/\/doi.org\/10.1097\/CEJ.0b013e328350b0ae.","journal-title":"Eur J Cancer Prev"},{"issue":"4","key":"429_CR61","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/modpathol.3801024","volume":"21","author":"AC Roden","year":"2008","unstructured":"Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol. 2008;21(4):455\u201363. https:\/\/doi.org\/10.1038\/modpathol.3801024.","journal-title":"Mod Pathol"},{"issue":"1","key":"429_CR62","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/PAI.0b013e318266476c","volume":"21","author":"CR Taylor","year":"2013","unstructured":"Taylor CR, Siddiqi IN, Brody GS. Anaplastic large cell lymphoma occurring in association with breast implants: review of pathologic and immunohistochemical features in 103 cases. Appl Immunohistochem Mol Morphol. 2013;21(1):13\u201320. https:\/\/doi.org\/10.1097\/PAI.0b013e318266476c.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"429_CR63","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.smim.2009.03.003","volume":"21","author":"F van Wijk","year":"2009","unstructured":"van Wijk F, Cheroutre H. Intestinal T cells: facing the mucosal immune dilemma with synergy and diversity. Semin Immunol. 2009;21(3):130\u20138. https:\/\/doi.org\/10.1016\/j.smim.2009.03.003.","journal-title":"Semin Immunol"},{"issue":"1","key":"429_CR64","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","volume":"118","author":"J Delabie","year":"2011","unstructured":"Delabie J, Holte H, Vose JM, et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood. 2011;118(1):148\u201355.","journal-title":"Blood"},{"issue":"8","key":"429_CR65","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1038\/leu.2013.41","volume":"27","author":"SY Tan","year":"2013","unstructured":"Tan SY, Chuang SS, Tang T, Tan L, Ko YH, Chuah KL, et al. Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8alphaalpha phenotype. Leukemia. 2013;27(8):1688\u201396. https:\/\/doi.org\/10.1038\/leu.2013.41.","journal-title":"Leukemia"},{"issue":"6","key":"429_CR66","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.humpath.2012.10.002","volume":"44","author":"AL Wilson","year":"2013","unstructured":"Wilson AL, Swerdlow SH, Przybylski GK, Surti U, Choi JK, Campo E, et al. Intestinal gammadelta T-cell lymphomas are most frequently of type II enteropathy-associated T-cell type. Hum Pathol. 2013;44(6):1131\u201345. https:\/\/doi.org\/10.1016\/j.humpath.2012.10.002.","journal-title":"Hum Pathol"},{"issue":"10","key":"429_CR67","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1097\/PAS.0b013e318222dfcd","volume":"35","author":"JK Chan","year":"2011","unstructured":"Chan JK, Chan AC, Cheuk W, Wan SK, Lee WK, Lui YH, et al. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent gammadelta T-cell receptor expression. Am J Surg Pathol. 2011;35(10):1557\u201369. https:\/\/doi.org\/10.1097\/PAS.0b013e318222dfcd.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"429_CR68","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.humpath.2013.10.038","volume":"45","author":"K Kikuma","year":"2014","unstructured":"Kikuma K, Yamada K, Nakamura S, et al. Detailed clinicopathological characteristics and possible lymphomagenesis of type II intestinal enteropathy-associated T-cell lymphoma in Japan. Hum Pathol. 2014;45(6):1276\u201384.","journal-title":"Hum Pathol"},{"issue":"5","key":"429_CR69","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","volume":"132","author":"RJ Deleeuw","year":"2007","unstructured":"Deleeuw RJ, Zettl A, Klinker E, et al. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology. 2007;132(5):1902\u201311. https:\/\/doi.org\/10.1053\/j.gastro.2007.03.036.","journal-title":"Gastroenterology"},{"issue":"22","key":"429_CR70","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1182\/blood-2013-07-512830","volume":"122","author":"AM Perry","year":"2013","unstructured":"Perry AM, Warnke RA, Hu Q, Gaulard P, Copie-Bergman C, Alkan S, et al. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood. 2013;122(22):3599\u2013606. https:\/\/doi.org\/10.1182\/blood-2013-07-512830.","journal-title":"Blood"},{"issue":"1","key":"429_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/hon.2317","volume":"35","author":"R Matnani","year":"2017","unstructured":"Matnani R, Ganapathi KA, Lewis SK, Green PH, Alobeid B, Bhagat G. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update. Hematol Oncol. 2017;35(1):3\u201316. https:\/\/doi.org\/10.1002\/hon.2317.","journal-title":"Hematol Oncol"},{"issue":"7","key":"429_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068343","volume":"8","author":"E Margolskee","year":"2013","unstructured":"Margolskee E, Jobanputra V, Lewis SK, Alobeid B, Green PH, Bhagat G. Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features. PLoS One. 2013;8(7):e68343. https:\/\/doi.org\/10.1371\/journal.pone.0068343.","journal-title":"PLoS One"},{"issue":"4 Suppl 1","key":"429_CR73","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1053\/j.gastro.2005.02.027","volume":"128","author":"C Catassi","year":"2005","unstructured":"Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology. 2005;128(4 Suppl 1):S79\u201386.","journal-title":"Gastroenterology"},{"issue":"15","key":"429_CR74","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1002\/cncr.26700","volume":"118","author":"RZ Sharaiha","year":"2012","unstructured":"Sharaiha RZ, Lebwohl B, Reimers L, Bhagat G, Green PH, Neugut AI. Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008. Cancer. 2012;118(15):3786\u201392. https:\/\/doi.org\/10.1002\/cncr.26700.","journal-title":"Cancer"},{"issue":"5","key":"429_CR75","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.dld.2012.12.001","volume":"45","author":"G Malamut","year":"2013","unstructured":"Malamut G, Chandesris O, Verkarre V, et al. Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study. Dig Liver Dis. 2013;45(5):377\u201384.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"429_CR76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bpg.2009.11.002","volume":"24","author":"JM van de Water","year":"2010","unstructured":"van de Water JM, Cillessen SA, Visser OJ, Verbeek WH, Meijer CJ, Mulder CJ. Enteropathy associated T-cell lymphoma and its precursor lesions. Best Pract Res Clin Gastroenterol. 2010;24(1):43\u201356. https:\/\/doi.org\/10.1016\/j.bpg.2009.11.002.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"4","key":"429_CR77","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s10620-007-9952-8","volume":"53","author":"M Silano","year":"2008","unstructured":"Silano M, Volta U, Vincenzi AD, Dessi M, Vincenzi MD, Collaborating Centers of the Italian Registry of the Complications of Coeliac D. Effect of a gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease. Dig Dis Sci. 2008;53(4):972\u20136. https:\/\/doi.org\/10.1007\/s10620-007-9952-8.","journal-title":"Dig Dis Sci"},{"issue":"17","key":"429_CR78","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMra071600","volume":"357","author":"PH Green","year":"2007","unstructured":"Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357(17):1731\u201343. https:\/\/doi.org\/10.1056\/NEJMra071600.","journal-title":"N Engl J Med"},{"issue":"1","key":"429_CR79","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1423-0127-19-88","volume":"19","author":"F Megiorni","year":"2012","unstructured":"Megiorni F, Pizzuti A. HLA-DQA1 and HLA-DQB1 in celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed Sci. 2012;19(1):88. https:\/\/doi.org\/10.1186\/1423-0127-19-88.","journal-title":"J Biomed Sci"},{"issue":"1","key":"429_CR80","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","volume":"136","author":"G Malamut","year":"2009","unstructured":"Malamut G, Afchain P, Verkarre V, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology. 2009;136(1):81\u201390.","journal-title":"Gastroenterology"},{"issue":"4","key":"429_CR81","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.dld.2011.10.008","volume":"44","author":"A Amiot","year":"2012","unstructured":"Amiot A, Allez M, Treton X, et al. High frequency of fatal haemophagocytic lymphohistiocytosis syndrome in enteropathy-associated T cell lymphoma. Dig Liver Dis. 2012;44(4):343\u20139.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"429_CR82","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/00004836-199806000-00026","volume":"26","author":"EL Berman","year":"1998","unstructured":"Berman EL, Zauber NP, Rickert RR, Diss TC, Isaacson PG. Enteropathy-associated T cell lymphoma with brain involvement. J Clin Gastroenterol. 1998;26(4):337\u201341. https:\/\/doi.org\/10.1097\/00004836-199806000-00026.","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"429_CR83","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1212\/01.WNL.0000066052.84194.6E","volume":"60","author":"C Gobbi","year":"2003","unstructured":"Gobbi C, Buess M, Probst A, et al. Enteropathy-associated T-cell lymphoma with initial manifestation in the CNS. Neurology. 2003;60(10):1718\u20139.","journal-title":"Neurology"},{"issue":"4","key":"429_CR84","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00281-012-0322-z","volume":"34","author":"G Malamut","year":"2012","unstructured":"Malamut G, Meresse B, Cellier C, Cerf-Bensussan N. Refractory celiac disease: from bench to bedside. Semin Immunopathol. 2012;34(4):601\u201313. https:\/\/doi.org\/10.1007\/s00281-012-0322-z.","journal-title":"Semin Immunopathol"},{"issue":"5","key":"429_CR85","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/PAS.0b013e318159b478","volume":"32","author":"A de Mascarel","year":"2008","unstructured":"de Mascarel A, Belleannee G, Stanislas S, et al. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype. Am J Surg Pathol. 2008;32(5):744\u201351.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"429_CR86","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/gut.51.3.372","volume":"51","author":"IN Farstad","year":"2002","unstructured":"Farstad IN, Johansen FE, Vlatkovic L, Jahnsen J, Scott H, Fausa O, et al. Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression. Gut. 2002;51(3):372\u20138. https:\/\/doi.org\/10.1136\/gut.51.3.372.","journal-title":"Gut"},{"issue":"4","key":"429_CR87","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.molimm.2012.01.014","volume":"50","author":"GJ Tack","year":"2012","unstructured":"Tack GJ, van Wanrooij RL, Langerak AW, et al. Origin and immunophenotype of aberrant IEL in RCDII patients. Mol Immunol. 2012;50(4):262\u201370. https:\/\/doi.org\/10.1016\/j.molimm.2012.01.014.","journal-title":"Mol Immunol"},{"issue":"4","key":"429_CR88","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/gutjnl-2012-302265","volume":"62","author":"F Schmitz","year":"2013","unstructured":"Schmitz F, Tjon JM, Lai Y, et al. Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II. Gut. 2013;62(4):509\u201319. https:\/\/doi.org\/10.1136\/gutjnl-2012-302265.","journal-title":"Gut"},{"issue":"5","key":"429_CR89","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","volume":"161","author":"A Zettl","year":"2002","unstructured":"Zettl A, Ott G, Makulik A, et al. Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol. 2002;161(5):1635\u201345.","journal-title":"Am J Pathol"},{"issue":"11","key":"429_CR90","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1038\/leu.2016.178","volume":"30","author":"A Nicolae","year":"2016","unstructured":"Nicolae A, Xi L, Pham TH, et al. Mutations in the JAK\/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas. Leukemia. 2016;30(11):2245\u20137.","journal-title":"Leukemia"},{"key":"429_CR91","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1038\/ncomms7025","volume":"6","author":"C Kucuk","year":"2015","unstructured":"Kucuk C, Jiang B, Hu X, et al. Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells. Nat Commun. 2015;6:6025. https:\/\/doi.org\/10.1038\/ncomms7025.","journal-title":"Nat Commun"},{"issue":"8","key":"429_CR92","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1097\/PAS.0b013e31822067d1","volume":"35","author":"A Garcia-Herrera","year":"2011","unstructured":"Garcia-Herrera A, Song JY, Chuang SS, Villamor N, Colomo L, Pittaluga S, et al. Nonhepatosplenic gammadelta T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol. 2011;35(8):1214\u201325. https:\/\/doi.org\/10.1097\/PAS.0b013e31822067d1.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"429_CR93","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/ajh.23213","volume":"87","author":"E Tse","year":"2012","unstructured":"Tse E, Gill H, Loong F, et al. Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group. Am J Hematol. 2012;87(7):663\u20138.","journal-title":"Am J Hematol"},{"issue":"3","key":"429_CR94","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/leu.2010.295","volume":"25","author":"SY Tan","year":"2011","unstructured":"Tan SY, Ooi AS, Ang MK, Koh M, Wong JC, Dykema K, et al. Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma. Leukemia. 2011;25(3):555\u20137. https:\/\/doi.org\/10.1038\/leu.2010.295.","journal-title":"Leukemia"},{"issue":"5","key":"429_CR95","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S0002-9440(10)65736-7","volume":"153","author":"A Chott","year":"1998","unstructured":"Chott A, Haedicke W, Mosberger I, et al. Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol. 1998;153(5):1483\u201390.","journal-title":"Am J Pathol"},{"issue":"10","key":"429_CR96","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/modpathol.2015.85","volume":"28","author":"S Tomita","year":"2015","unstructured":"Tomita S, Kikuti YY, Carreras J, Kojima M, Ando K, Takasaki H, et al. Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan. Mod Pathol. 2015;28(10):1286\u201396. https:\/\/doi.org\/10.1038\/modpathol.2015.85.","journal-title":"Mod Pathol"},{"issue":"7","key":"429_CR97","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/modpathol.2011.45","volume":"24","author":"J Sun","year":"2011","unstructured":"Sun J, Lu Z, Yang D, Chen J. Primary intestinal T-cell and NK-cell lymphomas: a clinicopathological and molecular study from China focused on type II enteropathy-associated T-cell lymphoma and primary intestinal NK-cell lymphoma. Mod Pathol. 2011;24(7):983\u201392. https:\/\/doi.org\/10.1038\/modpathol.2011.45.","journal-title":"Mod Pathol"},{"issue":"6","key":"429_CR98","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/leu.2016.13","volume":"30","author":"ML Nairismagi","year":"2016","unstructured":"Nairismagi ML, Tan J, Lim JQ, et al. JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma. Leukemia. 2016;30(6):1311\u20139.","journal-title":"Leukemia"},{"key":"429_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12602","volume":"7","author":"A Roberti","year":"2016","unstructured":"Roberti A, Dobay MP, Bisig B, Vallois D, Bo\u00e9chat C, Lanitis E, et al. Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations. Nat Commun. 2016;7:12602. https:\/\/doi.org\/10.1038\/ncomms12602.","journal-title":"Nat Commun"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11899-018-0429-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-018-0429-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-018-0429-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:01:28Z","timestamp":1659088888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11899-018-0429-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["429"],"URL":"https:\/\/doi.org\/10.1007\/s11899-018-0429-y","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"14 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}